It is recognized that the issue of AMR must be addressed by concerted efforts of government agencies, health providers, drug industry, professional organizations, academe and civil society. Surveillance is a fundamental part of an effective response to AMR problem. It is needed to detect resistant microorganisms, enable correct decisions to be made about treatment options and guide policy recommendations. The 2019 Antimicrobial Resistance Surveillance Program (ARSP) Annual Report is hence published to provide the most recent national estimate of antimicrobial resistance of bacteria of public health importance to the antibiotics commonly used against them. Such data is invaluable for policy development for the prevention and control of the emergence of AMR in the country as well as a useful guide in the treatment of patients.
Download the ARSP 2019 Annual Report Data Summary here